3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Hypogonadism
4
Eunuchism
2
Testicular Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Klinefelter Syndrome
1
Infertility
1
Fatigue Syndrome, Chronic
1
Carcinoma, Renal Cell
1
Interventions
Clomiphene
21
Metformin
14
Letrozole
11
cetrorelix
6
Triptorelin Pamoate
6
Menotropins
5
Inositol
5
follitropin alfa
4
Folic Acid
4
Chorionic Gonadotropin
4
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
ulipristal acetate
2
follitropin beta
2
Uterine Myomectomy
2
Therapeutics
2
Sugars
2
Psychiatric Rehabilitation
2
Progestins
2
Liraglutide
2
Goserelin
2
Gonadotropins
2
Flutamide
2
Fertilization in Vitro
2
Dydrogesterone
2
Cyclophosphamide
2
Counseling
2
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
drospirenone and ethinyl estradiol combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Infertility
×
testosterone undecanoate
×
Clear all
NCT01206270
2018-09-25
ALCeP
University of Roma La Sapienza
Phase 2/3
Completed
56 enrolled